Marco Puzzoni

1.5k total citations
50 papers, 737 citations indexed

About

Marco Puzzoni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Marco Puzzoni has authored 50 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Marco Puzzoni's work include Colorectal Cancer Treatments and Studies (18 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Hepatocellular Carcinoma Treatment and Prognosis (12 papers). Marco Puzzoni is often cited by papers focused on Colorectal Cancer Treatments and Studies (18 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Hepatocellular Carcinoma Treatment and Prognosis (12 papers). Marco Puzzoni collaborates with scholars based in Italy, United States and Belgium. Marco Puzzoni's co-authors include Mario Scartozzi, Laura Demurtas, Pina Ziranu, Eleonora Lai, Andrea Pretta, Stefano Mariani, Valeria Pusceddu, Clelia Donisi, Clelia Madeddu and Mara Persano and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Marco Puzzoni

44 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Puzzoni Italy	16	438	213	174	159	110	50	737
A. Reinacher-Schick Germany	11	441 1.0×	175 0.8×	146 0.8×	149 0.9×	68 0.6×	46	636
Dana A. Dominguez United States	12	206 0.5×	223 1.0×	148 0.9×	188 1.2×	69 0.6×	39	685
F. De Vita Italy	11	405 0.9×	198 0.9×	196 1.1×	220 1.4×	67 0.6×	37	691
Yifu He China	16	238 0.5×	283 1.3×	177 1.0×	191 1.2×	63 0.6×	78	717
Yuichiro Yokoyama Japan	15	287 0.7×	348 1.6×	95 0.5×	152 1.0×	104 0.9×	89	937
Hongyu Zhang China	16	334 0.8×	301 1.4×	149 0.9×	213 1.3×	44 0.4×	42	842
Peter Gaßmann Germany	16	381 0.9×	238 1.1×	114 0.7×	119 0.7×	33 0.3×	23	858
Dedong Cao China	17	396 0.9×	270 1.3×	205 1.2×	225 1.4×	61 0.6×	50	773
Zhibo Zhang China	17	453 1.0×	222 1.0×	265 1.5×	167 1.1×	32 0.3×	76	886
Marianna Silletta Italy	14	224 0.5×	157 0.7×	214 1.2×	87 0.5×	88 0.8×	42	613

Countries citing papers authored by Marco Puzzoni

Since Specialization

Citations

This map shows the geographic impact of Marco Puzzoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Puzzoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Puzzoni more than expected).

Fields of papers citing papers by Marco Puzzoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Puzzoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Puzzoni. The network helps show where Marco Puzzoni may publish in the future.

Co-authorship network of co-authors of Marco Puzzoni

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Puzzoni. A scholar is included among the top collaborators of Marco Puzzoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Puzzoni. Marco Puzzoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ziranu, Pina, Andrea Pretta, Flaviana Cau, et al.. (2024). CD44: A New Prognostic Marker in Colorectal Cancer?. Cancers. 16(8). 1569–1569. 16 indexed citations

Ziranu, Pina, Andrea Pretta, Raffaele Murru, et al.. (2023). New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression. Cancers. 15(4). 1212–1212. 9 indexed citations

Pretta, Andrea, Pina Ziranu, Riccardo Giampieri, et al.. (2022). Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment. Digestive and Liver Disease. 55(5). 655–660. 2 indexed citations

Zhang, Ruyi, Marco Puzzoni, Stefano Mariani, et al.. (2021). Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers. Cancer Science. 112(12). 4819–4833. 6 indexed citations

Pretta, Andrea, Clelia Donisi, Mara Persano, et al.. (2021). P-128 Influence of anti-diabetic medications on the outcomes of patients with pancreatic ductal adenocarcinoma and type 2 diabetes mellitus. Annals of Oncology. 32. S142–S142. 1 indexed citations

Lai, Eleonora, Marco Puzzoni, Pina Ziranu, et al.. (2021). Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study. Clinical Colorectal Cancer. 20(4). e253–e262. 2 indexed citations

Vega-Benedetti, Ana Florencia, Eleonora Loi, Loredana Moi, et al.. (2020). Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression. International Journal of Molecular Sciences. 21(12). 4494–4494. 25 indexed citations

Pasqualetti, Giuseppe, Marta Schirripa, Matteo Fassan, et al.. (2020). Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial. European Journal of Cancer. 133. 66–73. 20 indexed citations

Faloppi, Luca, Marco Puzzoni, Andrea Casadei‐Gardini, et al.. (2020). Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study. Targeted Oncology. 15(1). 115–126. 14 indexed citations

10.

Puzzoni, Marco, Francesca Montagnani, Giorgia Marisi, et al.. (2019). Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials. SHILAP Revista de lepidopterología. 1 indexed citations

11.

Lai, Eleonora, Marco Puzzoni, Pina Ziranu, et al.. (2019). New therapeutic targets in pancreatic cancer. Cancer Treatment Reviews. 81. 101926–101926. 76 indexed citations

12.

Schirripa, Marta, Giuseppe Pasqualetti, Riccardo Giampieri, et al.. (2018). Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study. Clinical Colorectal Cancer. 17(3). e601–e615. 11 indexed citations

13.

Astara, Giorgio, Eleonora Lai, Mariele Dessì, et al.. (2017). Medical management of malignant bowel obstruction: our center experience. Annals of Oncology. 28. vi15–vi15. 1 indexed citations

14.

Demurtas, Laura, Marco Puzzoni, Riccardo Giampieri, et al.. (2017). The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab. British Journal of Cancer. 117(3). 315–321. 18 indexed citations

15.

Solinas, Cinzia, Laura Demurtas, Marco Puzzoni, et al.. (2016). Tumor infiltrating lymphocytes in gastrointestinal tumors: Controversies and future clinical implications. Critical Reviews in Oncology/Hematology. 110. 106–116. 36 indexed citations

16.

Puzzoni, Marco, Nicola Silvestris, Francesco Leone, et al.. (2016). The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?. Targeted Oncology. 11(5). 593–603. 15 indexed citations

17.

Madeddu, Clelia, Martino Deidda, Alessandra Piras, et al.. (2016). Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy. Journal of Cardiovascular Medicine. 17. e12–e18. 91 indexed citations

18.

Puzzoni, Marco, et al.. (2015). A single institution survey on prevalence and management of severe cancer pain in patients with cancer of different sites. Annals of Oncology. 26. vi116–vi116. 1 indexed citations

19.

Massa, Elena, et al.. (2015). Clinical Outcome of Patients With Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment. Annals of Oncology. 26. vi50–vi50. 2 indexed citations

20.

Scartozzi, Mario, Riccardo Giampieri, Giuseppe Aprile, et al.. (2015). The distinctive molecular, pathological and clinical characteristics ofBRAF-mutant colorectal tumors. Expert Review of Molecular Diagnostics. 15(8). 979–987. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact